2022
DOI: 10.3390/biomedicines10112909
|View full text |Cite
|
Sign up to set email alerts
|

Characterization of microRNA Levels in Synovial Fluid from Knee Osteoarthritis and Anterior Cruciate Ligament Tears

Abstract: This study investigated modifications of microRNA expression profiles in knee synovial fluid of patients with osteoarthritis (OA) and rupture of the anterior cruciate ligament (ACL). Twelve microRNAs (26a-5p, 27a-3p, let7a-5p, 140-5p, 146-5p, 155-5p, 16-5p,186-5p, 199a-3p, 210-3p, 205-5p, and 30b-5p) were measured by real-time quantitative polymerase chain reaction (RT-qPCR) in synovial fluids obtained from 30 patients with ACL tear and 18 patients with knee OA. These 12 miRNAs were chosen on the basis of thei… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 46 publications
0
1
0
Order By: Relevance
“…Granulocytic-myeloid-derived suppressor cells (GMDSCs)-derived exosomal miRNAs miRNA-29A-3 P and miRNA-93-5 P can effectively reduce arthritis index, leukocyte Frontiers in Pharmacology frontiersin.org infiltration, and cartilage destruction in an OA mouse model by inhibiting inflammatory responses of T helper (Th1) cells, i.e., Th1 cells, and Th17 cells (Zhu et al, 2019). Exosomes with a high expression of miRNA-26a-5p can alleviate the injury of synovial fibroblasts induced by prostaglandin-endoperoxide synthase (Rizzi et al, 2022). Exosomal miRNA-100-5 P showed inhibitory effects on the mammalian target of rapamycin (mTOR) and inflammation thus having therapeutic effects on OA (Luo et al, 2019).…”
Section: The Exosome-based Treatment Has Multidimensionally Therapeut...mentioning
confidence: 99%
“…Granulocytic-myeloid-derived suppressor cells (GMDSCs)-derived exosomal miRNAs miRNA-29A-3 P and miRNA-93-5 P can effectively reduce arthritis index, leukocyte Frontiers in Pharmacology frontiersin.org infiltration, and cartilage destruction in an OA mouse model by inhibiting inflammatory responses of T helper (Th1) cells, i.e., Th1 cells, and Th17 cells (Zhu et al, 2019). Exosomes with a high expression of miRNA-26a-5p can alleviate the injury of synovial fibroblasts induced by prostaglandin-endoperoxide synthase (Rizzi et al, 2022). Exosomal miRNA-100-5 P showed inhibitory effects on the mammalian target of rapamycin (mTOR) and inflammation thus having therapeutic effects on OA (Luo et al, 2019).…”
Section: The Exosome-based Treatment Has Multidimensionally Therapeut...mentioning
confidence: 99%